focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: -3.25 (-8.72%)
Spread: 2.00 (6.061%)
Open: 37.50
High: 37.50
Low: 33.50
Prev. Close: 37.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing of shares

24 Oct 2007 12:24

Sareum Holdings PLC24 October 2007 Sareum Holdings plc ("Sareum" or the "Company") Placing of shares Application has been made for the admission of 112,941,176 shares to trading onAIM with admission expected to take place on 26 October 2007. The shares have been issued pursuant to the placing announced on 22 October2007. The number of shares being admitted will be 112,941,176 shares and not112,944,000 as previously announced. The balance of the placing shares,amounting to 25,947,713 Sareum shares, will be issued subject to approval atthe Company's AGM on 15 November 2007. For further information: Sareum Holdings plc01223 497700Tim Mitchell, Chief Executive Officer Buchanan Communications020 7466 5000Tim Anderson, Mary-Jane Johnson Grant Thornton Corporate Finance020 7383 5100Philip Secrett, Colin Aaronson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jun 201712:13 pmRNSChk1 Clinical Trials Update
31st May 20177:00 amRNSSierra Oncology Granted US and EU Patents
25th May 20177:00 amRNSSierra Oncology to Present at ASCO Annual Meeting
9th May 20177:00 amRNSSareum to Present at BioTrinity 2017
9th Mar 20177:00 amRNSDirector Shareholding
20th Feb 20177:00 amRNSHalf-year Results
9th Feb 20177:00 amRNSNotice of Interim Results
9th Jan 201712:05 pmRNSMilestone Payment from Chk1 Licence Agreement
22nd Dec 20169:47 amRNSResult of General Meeting
15th Dec 201611:38 amRNSResult of AGM
6th Dec 20167:00 amRNSDirectors' Remuneration & General Meeting
29th Nov 20167:00 amRNSSareum to Present at AACR-NCI-EORTC Conference
21st Nov 20167:00 amRNSNotice of AGM
2nd Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSSuccessful Outcome from TYK2 Feasibility Study
17th Oct 20167:00 amRNSJapan and Singapore Patent Grants
27th Sep 201612:02 pmRNSLicence agreement for Chk1 Inhibitor CCT245737
3rd Aug 20167:00 amRNSChina & HK Patent Grants for Sareum's Aurora+FLT3
28th Jul 20167:00 amRNSMovement in share price
23rd May 201612:00 pmRNSClinical Trials CHK1 Inhibitor CCT245737 to Open
17th May 20167:00 amRNSChange of Director
5th Apr 201610:38 amRNSCHK1 Approved for Clinical Trials
24th Mar 201611:54 amRNSPlacing
14th Mar 20167:00 amRNSIssue of Options
10th Mar 201612:55 pmRNSShare price movement
24th Feb 20167:01 amRNSResearch & Co-Development Collaborations Update
24th Feb 20167:00 amRNSHalf-Yearly Results for December 2015
1st Feb 20167:00 amRNSCHK1 Clinical Trial Application Submissions
15th Dec 201511:20 amRNSResult of AGM
15th Dec 20157:00 amRNSCHK1 Clinical Trial Applications
13th Nov 201510:15 amRNSNotice of AGM
26th Oct 20157:00 amRNSFinal Results
15th Sep 20157:00 amRNSUS and European Patent Grants for Aurora+FLT3
23rd Jul 20157:00 amRNSCHK1 Research Update
17th Jun 20157:00 amRNSFunding Award from Innovate UK
28th May 20157:00 amRNSPlacing
21st May 20157:00 amRNSSareum Launches New Website
12th May 20157:01 amRNSSareum to Present at BioTrinity 2015
7th May 20157:00 amRNSEarly Conclusion of Equity Swap Agreement
16th Mar 20157:00 amRNSChange of Adviser
20th Jan 20157:00 amRNSFurther US Patent Grant for Kinase Inhibitors
13th Oct 20148:20 amRNSHolding(s) in Company
1st Oct 20147:00 amRNSPromising Step in Psoriasis Drug Development
22nd Sep 20147:00 amRNSCHK1 Patent Update
2nd Jul 20147:00 amRNSJapanese Patent Grant for Kinase Inhibitors
30th Jun 20142:15 pmRNSTotal Voting Rights
26th Jun 20147:00 amRNSPreclinical Proof of Concept in TYK2 Programme
22nd Jan 20147:00 amRNSCHK1 Patent Update
25th Oct 20137:00 amRNSSareum to Present at London Investor Show
10th Sep 20127:00 amRNSFinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.